TissueTinker

Propulsé - BioTech | Hiver 2025

About the company

TissueTinker’s 3D bioprinted tumor models replicate critical aspects of cancer growth and metastasis to better mirror human tumors. Our proprietary solid tumor model library aims to accelerate therapeutic development with validated, accessible preclinical technology.

The founders

Benjamin Ringler
CEO/Co-founder
Isabelle Dummer
Co-founder
Madison Santos
Co-founder
icone tech
Information Technology

Audible Reality

Automne 2016

DeepSight

Hiver 2022
Energy

NovoPower

Hiver 2026